Research Archive — Page 178 of 194

lungs
August 9, 2012

New therapeutic target for cold, flu viruses identified

Viruses that cause acute respiratory infections — such as human metapneumovirus (HMPV) and flu — impair a set of immune system cells that should clear the virus from the lungs.
Now, Vanderbilt University investigators have discovered the signaling pathway that disables these immune cells.

By Leigh MacMillan
brain illustration
August 9, 2012

Study links rare genetic marker to brain cancer

Investigators from Vanderbilt-Ingram Cancer Center and three other cancer centers have identified a link between a rare genetic variant and the risk of developing glioma.

By Vanderbilt Health News
August 9, 2012

Team creates new view of body’s infection response

A new 3-D view of the body’s response to infection — and the ability to identify proteins involved in the response — could point to novel biomarkers and therapeutic agents for infectious diseases.

By Leigh MacMillan
August 9, 2012

Network approach yields glioblastoma clues

MicroRNA “regulatory networks” generated at Vanderbilt aid search for biomarkers and new drugs to treat glioblastoma, the most common and lethal primary brain tumor.

By Bill Snyder
August 7, 2012

Ancestry impacts smoking risk for lungs

Smoking is more detrimental to lung function in individuals with high proportions of African ancestry.

By Leigh MacMillan
August 2, 2012

Early HIV treatment also can prevent TB: study

Anti-retroviral therapy can prevent tuberculosis, even in people with early HIV disease.

By Bill Snyder